New Zealand looks set to be the latest country to ban the sale of OTC dry cough treatment pholcodine due to safety concerns.
National drug regulator Medsafe has recommended to New Zealand’s health ministry that the consent for pholcodine be revoked under Section...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?